Search Results - Nicholas P. van der Meulen

Alpha-PET with terbium-149: evidence and perspectives for radiotheragnostics by Cristina Müller, Christiaan Vermeulen, Ulli Köster, Karl Johnston, Andreas Türler, Roger Schibli, Nicholas P. van der Meulen

Connect to this object online.

44Sc for labeling of DOTA- and NODAGA-functionalized peptides: preclinical in vitro and in vivo investigations by Katharina A. Domnanich, Cristina Müller, Renata Farkas, Raffaella M. Schmid, Bernard Ponsard, Roger Schibli, Andreas Türler, Nicholas P. van der Meulen

Connect to this object online.

Production and characterization of no-carrier-added 161Tb as an alternative to the clinically-applied 177Lu for radionuclide therapy by Nadezda Gracheva, Cristina Müller, Zeynep Talip, Stephan Heinitz, Ulli Köster, Jan Rijn Zeevaart, Alexander Vögele, Roger Schibli, Nicholas P. van der Meulen

Connect to this object online.

47Sc as useful β--emitter for the radiotheragnostic paradigm: a comparative study of feasible production routes by Katharina A. Domnanich, Cristina Müller, Martina Benešová, Rugard Dressler, Stephanie Haller, Ulli Köster, Bernard Ponsard, Roger Schibli, Andreas Türler, Nicholas P. van der Meulen

Connect to this object online.

Production and separation of 43Sc for radiopharmaceutical purposes by Katharina A. Domnanich, Robert Eichler, Cristina Müller, Sara Jordi, Vera Yakusheva, Saverio Braccini, Martin Behe, Roger Schibli, Andreas Türler, Nicholas P. van der Meulen

Connect to this object online.

Simultaneous Visualization of ¹⁶¹Tb- and ¹⁷⁷Lu-Labeled Somatostatin Analogues Using Dual-Isotope SPECT Imaging by Francesca Borgna, Patrick Barritt, Pascal V. Grundler, Zeynep Talip, Susan Cohrs, Jan Rijn Zeevaart, Ulli Köster, Roger Schibli, Nicholas P. van der Meulen, Cristina Müller

Connect to this object online.

Therapeutic Potential of ⁴⁷Sc in Comparison to ¹⁷⁷Lu and ⁹⁰Y: Preclinical Investigations by Klaudia Siwowska, Patrycja Guzik, Katharina A. Domnanich, Josep M. Monné Rodríguez, Peter Bernhardt, Bernard Ponsard, Roger Hasler, Francesca Borgna, Roger Schibli, Ulli Köster, Nicholas P. van der Meulen, Cristina Müller

Connect to this object online.

Synthesis and Preclinical Evaluation of Radiolabeled [¹⁰³Ru]BOLD-100 by Barbara Happl, Marie Brandt, Theresa Balber, Katarína Benčurová, Zeynep Talip, Alexander Voegele, Petra Heffeter, Wolfgang Kandioller, Nicholas P. Van der Meulen, Markus Mitterhauser, Marcus Hacker, Bernhard K. Keppler, Thomas L. Mindt

Connect to this object online.

Combination of Proton Therapy and Radionuclide Therapy in Mice: Preclinical Pilot Study at the Paul Scherrer Institute by Cristina Müller, Maria De Prado Leal, Marco D. Dominietto, Christoph A. Umbricht, Sairos Safai, Rosalind L. Perrin, Martina Egloff, Peter Bernhardt, Nicholas P. van der Meulen, Damien C. Weber, Roger Schibli, Antony J. Lomax

Connect to this object online.

Highlight selection of radiochemistry and radiopharmacy developments by editorial board by Francisco Alves, Inês F. Antunes, Emiliano Cazzola, Frederik Cleeren, Bart Cornelissen, Antonia Denkova, Jonathan Engle, Alain Faivre-Chauvet, Nic Gillings, Jeroen J. M. A. Hendrikx, Amir R. Jalilian, Nicholas P. van der Meulen, Renata Mikolajczak, Oliver C. Neels, Maroor R. A. Pillai, Raymond Reilly, Sietske Rubow, Yann Seimbille, Sarah Spreckelmeyer, Wiktor Szymanski, Carlotta Taddei

Connect to this object online.